Episode

Digital Controls for Cancer Drug Trials? Irina Babina, Concr

Podcast
Mendelspod Podcast
Published
May 15, 2026
Duration seconds
263
Processing state
not_requested
Canonical source
https://www.mendelspod.com/p/digital-controls-for-cancer-drug
Audio
https://api.substack.com/feed/podcast/197554069/237211b14e63b3e93dfb8610983662ba.mp3
JSON
/v1/public/podcasts/mendelspod-podcast-742570/episodes/digital-controls-for-cancer-drug-trials-irina-babina-concr
Markdown
/podcast/mendelspod-podcast-742570/digital-controls-for-cancer-drug-trials-irina-babina-concr.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/digital-controls-for-cancer-drug-trials-irina-babina-concr/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/mendelspod-podcast-742570/digital-controls-for-cancer-drug-trials-irina-babina-concr.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com On today’s show, a fascinating discussion about digital twins for medical research— leading to the 64 million dollar question of how much of the current AI wave in healthcare may eventually prove real. Drawing on her background in cancer research and now as CEO of Concr, Dr. Irina Babina joins us to argue that the future of oncology may depend less on g…